BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Tenpoint Therapeutics Ltd. Appoints Carol Kearney as Chief Commercial Officer

  March 11, 2025

   · 

  3 min read
• 

  Gene therapy

  Roche Absorbs $2.4B Impairment in Overhaul of Spark Gene Therapy Unit

  Roche acquired Spark Therapeutics in 2019 for $4.8 billion.

  March 11, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Breast cancer

  Pfizer, Arvinas Post Mixed Late-Stage Breast Cancer Data for Closely Watched PROTAC Drug

  Vepdegestrant did not improve progression-free survival broadly but saw improvements in one specific patient cohort. Arvinas’ stock took a 43% tumble on the news, and analysts are downcast on the drug’s prospects.

  March 11, 2025

   · 

  2 min read

   · 

  Tristan Manalac
• Press Releases

  Kaerus Bioscience Successfully Completes Phase 1 Trial and Demonstrates Proof of Mechanism with its Novel BK Channel Modulator KER-0193 being developed for Fragile X Syndrome

  March 11, 2025

   · 

  2 min read
• Press Releases

  Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (HNSCC)

  March 11, 2025

   · 

  6 min read
• Press Releases

  Capricor Therapeutics to Present Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Update on March 19

  March 11, 2025

   · 

  4 min read
• Press Releases

  Artera Announces 1st Patient Enrolled in PROSTATE-IQ Trial to Reduce Burden of Hormone Therapy in Men with Prostate Cancer Recurrence After Prostatectomy

  March 11, 2025

   · 

  3 min read
• Press Releases

  Imbrium Therapeutics Achieves Last Patient Last Visit in Clinical Trial of Potential Treatment for Interstitial Cystitis/Bladder Pain Syndrome

  March 11, 2025

   · 

  4 min read
• 

  Manufacturing

  Viking Secures 1B Supply of Obesity Pill Candidate With $150M Prepayment Deal

  Analysts acknowledged the long-term manufacturing deal could dull Viking’s takeout prospects but hailed it as a smart move to ensure supply.

  March 11, 2025

   · 

  2 min read

   · 

  Annalee Armstrong
• Press Releases

  PreveCeutical Announces Update to Private Placement

  March 11, 2025

   · 

  3 min read